Page last updated: 2024-08-23

raloxifene hydrochloride and uric acid

raloxifene hydrochloride has been researched along with uric acid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantor, P; Deal, C; Eriksen, EF; Glass, EV; Krege, JH; Myers, SL; Omizo, M; Schwartz, EN; Wang, J	1
Akçay, A; Bavbek, N; Inegöl, I; Kanbay, M; Turgut, FH; Uz, E; Yanik, B; Yanik, T	1
Aurrekoetxea, I; del Agua, AR; Elorriaga, MA; Guéraud, F; Rodriguez, F; Ruiz-Larrea, MB; Ruiz-Sanz, JI	1

Trials

2 trial(s) available for raloxifene hydrochloride and uric acid

Article	Year
Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:11 Topics: Aged; Aged, 80 and over; Bone Density; Calcium; Collagen; Collagen Type I; Creatine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Kidney Function Tests; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Phosphorus; Procollagen; Raloxifene Hydrochloride; Teriparatide; Treatment Outcome; Uric Acid; Vomiting	2005
The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. Renal failure, 2007, Volume: 29, Issue:4 Topics: Aged; Alendronate; Bone Density Conservation Agents; C-Reactive Protein; Calcium; Etidronic Acid; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Raloxifene Hydrochloride; Risedronic Acid; Uric Acid	2007

Article

Year

Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:11

Topics: Aged; Aged, 80 and over; Bone Density; Calcium; Collagen; Collagen Type I; Creatine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Kidney Function Tests; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Phosphorus; Procollagen; Raloxifene Hydrochloride; Teriparatide; Treatment Outcome; Uric Acid; Vomiting

2005

The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women.

Renal failure, 2007, Volume: 29, Issue:4

Topics: Aged; Alendronate; Bone Density Conservation Agents; C-Reactive Protein; Calcium; Etidronic Acid; Female; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Raloxifene Hydrochloride; Risedronic Acid; Uric Acid

2007

Other Studies

1 other study(ies) available for raloxifene hydrochloride and uric acid

Article	Year
Involvement of G-463A MPO gene polymorphism in the response of postmenopausal women to hormone therapy. Menopause (New York, N.Y.), 2011, Volume: 18, Issue:5 Topics: Acetylcysteine; alpha-Tocopherol; Antioxidants; Estradiol; Female; Hormone Replacement Therapy; Humans; Intercellular Adhesion Molecule-1; Lipids; Malondialdehyde; Middle Aged; Peroxidase; Polymorphism, Genetic; Postmenopause; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uric Acid	2011

Article

Year

Involvement of G-463A MPO gene polymorphism in the response of postmenopausal women to hormone therapy.

Menopause (New York, N.Y.), 2011, Volume: 18, Issue:5

Topics: Acetylcysteine; alpha-Tocopherol; Antioxidants; Estradiol; Female; Hormone Replacement Therapy; Humans; Intercellular Adhesion Molecule-1; Lipids; Malondialdehyde; Middle Aged; Peroxidase; Polymorphism, Genetic; Postmenopause; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uric Acid

2011